描述
A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide protection from influenza by exposing the immune system to the virus (or parts of the virus) which stimulates an immunological defence against future exposure to the virus, or "antigen". This defence includes the production of humoral immunity through the development of antibodies (through memory B cells) and of cell-mediated immunity through the production of T-lymphocytes. Upon re-exposure to infectious influenza virus, the immune system is prepared to identify and destroy the virus as there are circulating antibodies that recognize that particular component of the virus that it was previously exposed to.
There are two basic types of vaccines available: inactivated influenza vaccine (IIV) and live attenuated influenza vaccine (LAIV). Inactivated vaccines contain a virus particle that has been grown in media and then subsequently killed, or inactivated, through exposure to heat or chemicals such as formaldehyde 3. Inactivated virus cannot replicate, and therefore cannot cause disease from infection, even in immunocompromised individuals. In contrast, live vaccines are produced from "wild-type" or disease-causing viruses that have been attenuated, or weakened, through various laboratory techniques. Live vaccines maintain their replicative ability.
产品
name:Flulaval 2011/2012
labeller:ID Biomedical Corporation of Quebec
ndc-id:
ndc-product-code:19515-888
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2011-07-01
ended-marketing-on:2011-07-01
dosage-form:Suspension
strength:
route:Intramuscular
fda-application-number:BLA125163
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Flulaval Quadrivalent 2013/2014
labeller:ID Biomedical Corporation of Quebec
ndc-id:
ndc-product-code:19515-895
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2013-08-15
ended-marketing-on:2013-08-15
dosage-form:Suspension
strength:
route:Intramuscular
fda-application-number:BLA125163
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Flulaval Quadrivalent 2014/2015
labeller:ID Biomedical Corporation of Quebec
ndc-id:
ndc-product-code:19515-891
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2014-07-01
ended-marketing-on:2014-06-27
dosage-form:Suspension
strength:
route:Intramuscular
fda-application-number:BLA125163
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Flulaval Quadrivalent 2014/2015
labeller:ID Biomedical Corporation of Quebec
ndc-id:
ndc-product-code:19515-894
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2014-07-01
ended-marketing-on:2014-06-27
dosage-form:Suspension
strength:
route:Intramuscular
fda-application-number:BLA125163
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Flulaval Quadrivalent 2015/2016
labeller:ID Biomedical Corporation of Quebec
ndc-id:
ndc-product-code:19515-898
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2015-07-01
ended-marketing-on:2015-06-30
dosage-form:Suspension
strength:
route:Intramuscular
fda-application-number:BLA125163
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Flulaval Quadrivalent 2015/2016
labeller:ID Biomedical Corporation of Quebec
ndc-id:
ndc-product-code:19515-901
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2015-07-01
ended-marketing-on:2015-06-30
dosage-form:Suspension
strength:
route:Intramuscular
fda-application-number:BLA125163
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Flulaval Quadrivalent 2016/2017
labeller:ID Biomedical Corporation of Quebec
ndc-id:
ndc-product-code:19515-903
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2016-07-01
ended-marketing-on:2016-05-31
dosage-form:Suspension
strength:
route:Intramuscular
fda-application-number:BLA125163
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Flulaval Quadrivalent 2016/2017
labeller:ID Biomedical Corporation of Quebec
ndc-id:
ndc-product-code:19515-908
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2016-07-01
ended-marketing-on:2016-05-31
dosage-form:Suspension
strength:
route:Intramuscular
fda-application-number:BLA125163
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Flulaval Quadrivalent 2017/2018
labeller:ID Biomedical Corporation of Quebec
ndc-id:
ndc-product-code:19515-896
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2017-07-07
ended-marketing-on:2017-07-07
dosage-form:Suspension
strength:
route:Intramuscular
fda-application-number:BLA125163
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
name:Flulaval Quadrivalent 2017/2018
labeller:ID Biomedical Corporation of Quebec
ndc-id:
ndc-product-code:19515-912
dpd-id:
ema-product-code:
ema-ma-number:
started-marketing-on:2017-07-07
ended-marketing-on:2017-07-07
dosage-form:Suspension
strength:
route:Intramuscular
fda-application-number:BLA125163
generic:false
over-the-counter:false
approved:true
country:US
source:FDA NDC
混合物
name:Flulaval Quadrivalent 2015/2016
ingredients:Influenza A virus A/California/7/2009 X-179A (H1N1) antigen (UV, formaldehyde inactivated) + Influenza A virus A/Switzerland/9715293/2013 NIB-88 (H3N2) antigen (UV, formaldehyde inactivated) + Influenza B virus B/Brisbane/60/2008 antigen (UV, formaldehyde inactivated) + Influenza B virus B/Phuket/3073/2013 antigen (UV, formaldehyde inactivated)
name:Flulaval Quadrivalent 2015/2016
ingredients:Influenza A virus A/California/7/2009 X-179A (H1N1) antigen (UV, formaldehyde inactivated) + Influenza A virus A/Switzerland/9715293/2013 NIB-88 (H3N2) antigen (UV, formaldehyde inactivated) + Influenza B virus B/Brisbane/60/2008 antigen (UV, formaldehyde inactivated) + Influenza B virus B/Phuket/3073/2013 antigen (UV, formaldehyde inactivated)
name:Flulaval Quadrivalent 2016/2017
ingredients:Influenza A virus A/California/7/2009 X-179A (H1N1) antigen (UV, formaldehyde inactivated) + Influenza A virus A/Hong Kong/4801/2014 X-263B (H3N2) antigen (UV, formaldehyde inactivated) + Influenza B virus B/Brisbane/60/2008 antigen (UV, formaldehyde inactivated) + Influenza B virus B/Phuket/3073/2013 antigen (UV, formaldehyde inactivated)
name:Flulaval Quadrivalent 2016/2017
ingredients:Influenza A virus A/California/7/2009 X-179A (H1N1) antigen (UV, formaldehyde inactivated) + Influenza A virus A/Hong Kong/4801/2014 X-263B (H3N2) antigen (UV, formaldehyde inactivated) + Influenza B virus B/Brisbane/60/2008 antigen (UV, formaldehyde inactivated) + Influenza B virus B/Phuket/3073/2013 antigen (UV, formaldehyde inactivated)
name:Flulaval 2011/2012
ingredients:Influenza A virus A/California/7/2009 X-181 (H1N1) antigen (UV, formaldehyde inactivated) + Influenza A virus A/Victoria/210/2009 X-187 (H3N2) antigen (UV, formaldehyde inactivated) + Influenza B virus B/Brisbane/60/2008 antigen (UV, formaldehyde inactivated)
name:Flulaval Quadrivalent 2013/2014
ingredients:Influenza A virus A/California/7/2009 X-179A (H1N1) antigen (UV, formaldehyde inactivated) + Influenza A virus A/Texas/50/2012 X-223A (H3N2) antigen (UV, formaldehyde inactivated) + Influenza B virus B/Brisbane/60/2008 antigen (UV, formaldehyde inactivated) + Influenza B virus B/Massachusetts/2/2012 BX-51B antigen (UV, formaldehyde inactivated)
name:Flulaval Quadrivalent 2014/2015
ingredients:Influenza A virus A/California/7/2009 X-179A (H1N1) antigen (UV, formaldehyde inactivated) + Influenza A virus A/Texas/50/2012 X-223A (H3N2) antigen (UV, formaldehyde inactivated) + Influenza B virus B/Brisbane/60/2008 antigen (UV, formaldehyde inactivated) + Influenza B virus B/Massachusetts/2/2012 BX-51B antigen (UV, formaldehyde inactivated)
name:Flulaval Quadrivalent 2014/2015
ingredients:Influenza A virus A/California/7/2009 X-179A (H1N1) antigen (UV, formaldehyde inactivated) + Influenza A virus A/Texas/50/2012 X-223A (H3N2) antigen (UV, formaldehyde inactivated) + Influenza B virus B/Brisbane/60/2008 antigen (UV, formaldehyde inactivated) + Influenza B virus B/Massachusetts/2/2012 BX-51B antigen (UV, formaldehyde inactivated)
name:Flulaval Quadrivalent 2017/2018
ingredients:Influenza A virus A/Hong Kong/4801/2014 X-263B (H3N2) antigen (UV, formaldehyde inactivated) + Influenza A virus A/Singapore/GP1908/2015 IVR-180 (H1N1) antigen (UV, formaldehyde inactivated) + Influenza B virus B/Brisbane/60/2008 antigen (UV, formaldehyde inactivated) + Influenza B virus B/Phuket/3073/2013 antigen (UV, formaldehyde inactivated)
name:Flulaval Quadrivalent 2017/2018
ingredients:Influenza A virus A/Hong Kong/4801/2014 X-263B (H3N2) antigen (UV, formaldehyde inactivated) + Influenza A virus A/Singapore/GP1908/2015 IVR-180 (H1N1) antigen (UV, formaldehyde inactivated) + Influenza B virus B/Brisbane/60/2008 antigen (UV, formaldehyde inactivated) + Influenza B virus B/Phuket/3073/2013 antigen (UV, formaldehyde inactivated)